ACORN BIOVENTURES, L.P. 13D and 13G filings for Y-mAbs Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-06 3:59 pm Purchase | 2023-12-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB | ACORN BIOVENTURES, L.P. | 2,761,825 6.300% | 435,297 (+18.71%) | Filing |
| 2023-04-03 1:46 pm Purchase | 2023-03-15 | 13G | Y-mAbs Therapeutics, Inc. YMAB | ACORN BIOVENTURES, L.P. | 2,326,528 5.300% | 2,326,528 (New Position) | Filing |